Literature DB >> 34041823

Risk and risk reduction in trials of heart failure with reduced ejection fraction: absolute or relative?

Harriette G C Van Spall1,2,3, Tauben Averbuch1, Kevin Damman4, Adriaan A Voors4.   

Abstract

Entities:  

Year:  2021        PMID： 34041823     DOI： 10.1002/ejhf.2248

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  2 in total

Review 1.  The need for increased pragmatism in cardiovascular clinical trials.

Authors:  Muhammad Shariq Usman; Harriette G C Van Spall; Stephen J Greene; Ambarish Pandey; Darren K McGuire; Ziad A Ali; Robert J Mentz; Gregg C Fonarow; John A Spertus; Stefan D Anker; Javed Butler; Stefan K James; Muhammad Shahzeb Khan
Journal:  Nat Rev Cardiol       Date:  2022-05-17       Impact factor: 49.421

2.  Neuromodulation in heart failure.

Authors:  Faiez Zannad
Journal:  Eur Heart J Suppl       Date:  2022-08-17       Impact factor: 1.624
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.